Jeffrey A. Chodakewitz's most recent trade in Praxis Precision Medicines Inc was a trade of 10,520 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines... | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 10,520 | 10,520 | - | - | Stock Option (Right to Buy) | |
| Schrodinger Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 9,341 | 9,341 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 5,997 | 17,247 (0%) | 0% | 0 | Common Stock | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 5,900 | 17,700 | - | 0 | Common Stock | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2024 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2024 | 26,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2024 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2024 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Schrodinger Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 8,550 | 8,550 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 5,000 | 11,250 (0%) | 0% | 0 | Common Stock | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,566 | 8,566 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 5,900 | 11,800 | - | 0 | Common Stock | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 26,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Schrodinger Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 6,250 | 6,250 (0%) | 0% | 0 | Common Stock | |
| Praxis Precision Medicines... | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 28,981 | 28,981 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,900 | 5,900 | - | 0 | Common Stock | |
| Schrodinger Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 14,907 | 14,907 | - | - | Stock Option (right to buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 22,753 | 22,753 | - | - | Stock Option (Right to Buy) | |
| Schrodinger Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 8,736 | 8,736 | - | - | Stock Option (right to buy) | |
| Adicet Bio Inc | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Jeffrey A. Chodakewitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2021 | 38,579 | 38,579 | - | - | Stock Option (Right to Buy) |